MOTION for Pro Hac Vice Appearance of Attorney Jordana A. Garellek - filed by Wockhardt Ltd., Wockhardt USA LLC. (Neiderman, Matt) (Entered: 06/03/2013)
SO ORDERED, re (15 in 1:11-cv-00705-LPS, 20 in 1:11-cv-00704-LPS, 13 in 1:11-cv-00758-LPS, 11 in 1:11-cv-00757-LPS) CONSOLIDATION STIPULATION AND ORDER -- These Actions Are Consolidated For All Purposes; and All Papers Shall Be Filed In Civil Action No. 11-704-LPS. Signed by Judge Leonard P. Stark on 9/26/11. Associated Cases: 1:11-cv-00704-LPS, 1:11-cv-00705-LPS, 1:11-cv-00757-LPS, 1:11-cv-00758-LPS(ntl) (Entered: 09/26/2011)
STIPULATION AND ORDER FOR CONSOLIDATION by Actavis Inc., Actavis South Atlantic LLC, Avanir Holding Company, Avanir Pharmaceuticals Inc., Center for Neurological Study, Center for Neurologic Study, Impax Laboratories Inc., Wockhardt Ltd., Wockhardt USA LLC, Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc.. (Blumenfeld, Jack) (Entered: 09/22/2011)
MOTION for Pro Hac Vice Appearance of Attorney Frederick R. Ball, Anthony J. Fitzpatrick, Vincent L. Capuano, Carolyn A. Alenci - filed by Wockhardt Ltd., Wockhardt USA LLC. (Attachments: # 1 Text of Proposed Order, # 2 Certification of Frederick R. Ball, # 3 Certification of Anthony J. Fitzpatrick, # 4 Certification of Vincent L. Capuano, # 5 Certification of Carolyn A. Alenci)(Neiderman, Matt) (Entered: 09/16/2011)
MOTION for Pro Hac Vice Appearance of Attorney F. Dominic Cerrito, Eric Stops and Daniel C. Wiesner - filed by Avanir Holding Company, Avanir Pharmaceuticals Inc., Center for Neurologic Study. (Blumenfeld, Jack) (Entered: 09/16/2011)
STIPULATION TO EXTEND TIME to Respond to Complaint to October 14, 2011 - filed by Wockhardt Ltd., Wockhardt USA LLC. (Neiderman, Matt) (Entered: 09/14/2011)
DECLARATION OF MAILING (as to service on Wockhardt, Ltd.) by Avanir Holding Company, Avanir Pharmaceuticals Inc., Center for Neurologic Study. (Attachments: # 1 Exhibit A & B)(Blumenfeld, Jack) (Entered: 09/06/2011)
SUMMONS Returned Executed by Avanir Pharmaceuticals Inc., Avanir Holding Company, Center for Neurologic Study. Wockhardt USA LLC served on 8/30/2011, answer due 9/20/2011. (Blumenfeld, Jack) (Entered: 08/30/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Avanir Holding Company identifying Corporate Parent Avanir Pharmaceuticals Inc. for Avanir Holding Company. (lid) (Entered: 08/30/2011)
Disclosure Statement pursuant to Rule 7.1 filed by Avanir Pharmaceuticals Inc. identifying Other Affiliate T. Rowe Price for Avanir Pharmaceuticals Inc.. (lid) Modified on 9/1/2011 (dzs, ). (Entered: 08/30/2011)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/19/2011. Date of Expiration of Patent: 8/13/2026 '282; 1/26/2016 '115.Thirty Month Stay Deadline: 1/19/2014. (lid) (Entered: 08/30/2011)